is there a shortage of semaglutide Explainer: What's behind the scramble for semaglutide? How FDA Crackdowns Are Affecting

FDA approves new drug treatment for chronic weight management, first since 2014, U.S

Eli Lilly delivered a Q1 2026 trifectaearnings beat, raised full-year guidance, and early-April FDA approval of Foundayo, the first oral GLP-1 with no food or water restrictionswidening its lead over Novo Nordisk just as the race for a convenient weight-loss pill heats up

Possible side effects include: Gastrointestinal issues Bloating, cramps, or upset stomach Allergic reactions Rash, itching, or breathing difficulties in rare cases Skin rashes Especially in people with sensitive skin or allergies Thyroid imbalance Overuse may affect hormone levels over time Doctors advise against using glutathione during pregnancy or breastfeeding due to limited research on safety in these conditions

Identification of Nrf2-regulated genes induced by chemopreventive isothiocyanate PEITC by oligonucleotide microarray

Diabetes rates have stabilized since 2023

Leg cramps during semaglutide treatment can occur at different times and vary in severity